|
CHURC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.199500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.252600E-01 |
| Normal-vs-Stage2 |
1.654400E-01 |
| Normal-vs-Stage3 |
2.34450000002884E-06 |
| Normal-vs-Stage4 |
1.84430000049751E-07 |
| Stage1-vs-Stage2 |
3.416400E-01 |
| Stage1-vs-Stage3 |
7.68780000000024E-05 |
| Stage1-vs-Stage4 |
1.53085999999858E-05 |
| Stage2-vs-Stage3 |
6.607900E-02 |
| Stage2-vs-Stage4 |
1.395710E-02 |
| Stage3-vs-Stage4 |
3.987200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.636900E-04 |
| Normal-vs-AfricanAmerican |
1.053690E-02 |
| Normal-vs-Asian |
2.284800E-01 |
| Caucasian-vs-AfricanAmerican |
4.194200E-01 |
| Caucasian-vs-Asian |
5.715400E-01 |
| AfricanAmerican-vs-Asian |
8.088800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.571400E-04 |
| Normal-vs-Female |
5.263700E-03 |
| Male-vs-Female |
8.933600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.098400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.378400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.71939999999271E-05 |
| Normal-vs-Age(81-100Yrs) |
1.943550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.571200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.427000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.114000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.618200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.182400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.195400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.979700E-02 |
| Normal-vs-Grade 2 |
9.336400E-01 |
| Normal-vs-Grade 3 |
2.83819999946644E-07 |
| Normal-vs-Grade 4 |
6.6906999940386E-09 |
| Grade 1-vs-Grade 2 |
8.294300E-02 |
| Grade 1-vs-Grade 3 |
1.585900E-04 |
| Grade 1-vs-Grade 4 |
1.54440999999839E-05 |
| Grade 2-vs-Grade 3 |
1.73179999995998E-06 |
| Grade 2-vs-Grade 4 |
6.70140000158526E-08 |
| Grade 3-vs-Grade 4 |
1.502050E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.609000E-01 |
| Normal-vs-ccB subtype |
7.28360000090689E-08 |
| ccA subtype-vs-ccB subtype |
2.84299994657289E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.357700E-03 |
| Normal-vs-N1 |
8.14640000000866E-05 |
| N0-vs-N1 |
5.738900E-03 |
|
|
